HotPennyStockNews.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We propel those victors directly to your email inbox first ahead of the rest of the marketplace gets a prospect.
Los Angelas, CA -- (SBWIRE) -- 09/18/2012 -- Jazz Pharmaceutic (NasdaqNM:JAZZ) reported EPS of 2.334. For the Current Fiscal year, the company is expected to report EPS of 4.78. For the Next Quarter and Next Year, the company is expected to report EPS of 1.48 and 5.73 respectively. At Current Market Price, JAZZ is in distance of +17.36% from its 50-day Moving Average price of $47.1109 and +18.51% from its 200-day Moving Average price of $46.653. Jazz Pharmaceuticals (JAZZ) had a key breakout on Monday. It has been in a beautiful rising channel since 2009, going from the single digits to the mid 50’s. Most recently, it formed a big wedge, and in the last few days, it’s gone from 43 to 56, spiking up on Monday to 56.26, jumping 7.17 or 15%, on 4.2 million shares. That’s the biggest volume since May. More importantly, the wedge and previous high were taken out, and it’s now in new all-time high territory. It may extend this run into the mid 60’s, and then the mid 70’s.
Can JAZZ Touch $60 : Find Out Here
Kratos Defense & (NasdaqNM:KTOS) reported EPS of -1.032. For the Current Fiscal year, the company is expected to report EPS of -0.32. For the Next Quarter and Next Year, the company is expected to report EPS of 0.09 and 0.30 respectively. At Current Market Price, KTOS is in distance of +14.37% from its 50-day Moving Average price of $5.0711 and +6.24% from its 200-day Moving Average price of $5.4593. Kratos Defense & Security Solutions Inc (NASDAQ:KTOS) jumped up 10.46% to $5.60. The Company announced that Es’hailSat has selected Kratos’ Integral Systems Europe S.A.S (ISE). Es’hailSat is the Qatar Satellite Company. Under the terms of the contract, ISE will design, build, and test the system in ISE’s integration facility in Labege near Toulouse, France, prior to shipment to and installation in Qatar.
Get Your Free Trend Analysis copy Today On KTOS Here
Neuralstem, Inc. (AMEX:CUR) is +0.16 - +13.91% from the previous close of $1.15. It traded between $1.06 - 1.35 with total traded volume of 4604482 shares. Keep a close eye on CUR, as the stock has been showing unusual moves over the past weeks. At Current market price, CUR has recovered +211.90% from its 52-week Low of 0.42 and has Pulled back -33.16% from its 52-week high of 1.96. Neuralstem, Inc. (NYSE:CUR), on Friday, stated that it inteds, subject to market and other conditions, to begina a public offering of its common stock. The company intends to use the offering’s net proceeds for general corporate reasons, like research and development expenditures, working capital, capital expenditures, clinical examination expenditures, along with various general corporate purposes. For investors focus on the performance of the stocks so the CUR showed weekly ahead performance of 71.64% which was maintained for the month at 121.15%. Correspondingly the positive performance for the quarter was remained 27.78% and if took notice on yearly performance that was -19.58% whereas the year to date performance halted at 18.56%.
Get Your Free Trend Analysis copy Today On CUR Here
Savient Pharmaceu (NGM:SVNT) reported EPS of -1.546. For the Current Fiscal year, the company is expected to report EPS of -1.64. For the Next Quarter and Next Year, the company is expected to report EPS of -0.46 and -1.01 respectively. At Current Market Price, SVNT is in distance of +87.34% from its 50-day Moving Average price of $1.1146 and +62.32% from its 200-day Moving Average price of $1.2864. Savient Pharmaceuticals Inc. (NASDAQ: SVNT), a specialty biopharmaceutical company focused on commercialization of KRYSTEXXA in the U.S. SVNT shares finished 14.13% higher at $2.10 on Monday, extending its gains in the last three trading sessions to over 31%. Last month, SVNT had reported a narrower loss in its second quarter. SVNT reported net loss of $16.4 million, or $0.23 per share for the second quarter, compared to a net loss of $30.2 million, or $0.43 per share reported for the same period in the previous year. The company ended the second quarter with $142.2 million in cash and short-term investments.
Get Your Free Trend Analysis copy Today On CUR Here
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)